(Q39366397)

11 September 2017

title

Persistence of Epstein-Barr viral nuclear antigen (EBNA) in cells entering the EB viral cycle (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55398

9 April 2022

Persistence of Epstein-barr viral nuclear antigen (EBNA) in cells entering the eb viral cycle (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

9 April 2022

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55398

9 April 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

9 April 2022

author name string

ErnbergI

1

1 reference

11 September 2017

G Masucci

2

1 reference

11 September 2017

G Klein

3

1 reference

11 September 2017

G. Masucci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55398

9 April 2022

G. Klein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55398

9 April 2022

language of work or name

English

0 references

publication date

1 February 1976

1 reference

11 September 2017

15 February 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=55398

full work available at URL

9 April 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910170208

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910170208

9 April 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

International Journal of Cancer

9 April 2022

published in

1 reference

11 September 2017

volume

17

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

197-203

1 reference

Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol

11 September 2017

cites work

1

20

391

Adams

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Studies of epstein-barr virus (ebv)-associated nuclear antigen. I. Assay in human lymphoblastoid cell lines by direct and indirect determination of125i-igg binding

9 April 2022

2

15

606

Brown

1975

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay

9 April 2022

Studies on Epstein-Barr virus-associated antigens

3

0 references

4

254

516

Ernberg

1975

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence

9 April 2022

5

53

61

Ernberg

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).

9 April 2022

6

69

83

Gerber

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Appearance of Epstein-Barr virus-associated antigens in infected Raji cells

9 April 2022

7

45

10

Gergely

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines

9 April 2022

8

7

293

Gergely

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints)

9 April 2022

9

69

78

Hampar

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells

9 April 2022

11

8

272

Henle

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Differential reactivity of human serums with early antigens induced by Epstein-Barr virus

9 April 2022

12

169

188

Henle

1970

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

PRODUCTION OF "TUMOR-SPECIFIC" ANTIGENS BY ONCOGENIC VIRUSES DURING ACUTE CYTOLYTIC INFECTIONS

9 April 2022

13

53

12

Hoggan

1965

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction

9 April 2022

16

55

1628

Klein

1966

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV

9 April 2022

18

3

232

Klein

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Classification and biological nature of established human hematopoietic cell lines

9 April 2022

21

15

321

Nilsson

1975

1 reference

https://api.crossref.org/works/10.1002/IJC.2910170208

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells

9 April 2022

22

56

1699

Old

0 references

Identifiers

1 reference

11 September 2017

1 reference